Urology

Filter

Diabetic Kidney Disease Risk Linked to RAR inflammatory marker - EMJ

Novel Inflammatory-Nutritional Marker Linked to Diabetic Kidney Disease Risk

December 2025

A large NHANES analysis shows the red cell distribution width-to-albumin ratio is strongly associated with diabetic kidney disease risk in adults with diabetes.

Bladder Cancer Gene Variants Offer Potential Treatment

GENETIC SIGNATURES of non-invasive bladder cancer have recently been reported by researchers at the University of Leeds, Leeds, UK, highlighting the…

Significant Mortality Benefits of Mechanical Valves

MECHANICAL valves have very good long-term mortality benefits and should be used more often, particularly in younger patients who require mitral-valve…

New Probe Improves the Ability to Predict Heart Attacks

The result of a recent study could change the way in which the vasculature of the heart is investigated. Read the article and find out more

Urinary Tract Infection Resistant Mutation Identified

A MUTATION altering the effect that levofloxacin, a quinolone antibiotic, has on pathogens causing urinary tract infections (UTI) has been identified by…

Immunotherapy to Advance Prostate Cancer Treatment

A NOVEL immunotherapy strategy for the treatment of prostate cancer using DNA-encoded monoclonal antibodies (DMAb) has shown promising results according…

Action-Packed August

Here in the EMJ offices, August would best be described by the team as a whirlwind, with not one, but six brand new publications ready for you to choose…

Significant Improvement in Prostate Cancer Survival Rates Found

SIGNIFICANT improvements to survival rates in prostate cancer patients have been found to result from the addition of abiraterone to hormone therapy at…

Abiraterone Acetate Plus Prednisone Provided Significant Clinical Benefit in Patients with High-Risk Metastatic Hormone-Naïve Prostate Cancer (mHNPC), Improving Overall Survival and Radiographic Progression-Free Survival

Beerse, Belgium, 3 June, 2017 – Janssen-Cilag International NV today announced data from the pivotal Phase 3 LATITUDE clinical trial, which showed Zytiga…

Loading posts...

« Previous 1 … 36 37 38 39 40 … 43 Next »